Template:Fenofibrate: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
Line 39: Line 39:
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | TRIGLIDE <sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | TRIGLIDE <sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate dosage forms and strengths|Dosage Forms and Strengths]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE dosage forms and strengths|Dosage Forms and Strengths]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE warnings and precautions|Warnings and Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE adverse reactions|Adverse Reactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate drug interactions|Drug Interactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE drug interactions|Drug Interactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate use in specific populations|Use in Specific Populations]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE use in specific populations|Use in Specific Populations]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE overdosage|Overdosage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE description|Description]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE clinical pharmacology|Clinical Pharmacology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE nonclinical toxicology|Nonclinical Toxicology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate clinical studies|Clinical Studies]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE patient counseling information|Patient Counseling Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Fenofibrate labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[TRIGLIDE labels and packages|Labels and Packages]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Fenofibrate
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Fenofibrate

Latest revision as of 19:31, 12 February 2014

Fenofibrate
ANTARA® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
TRIGLIDE ® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Fenofibrate
ClinicalTrials.gov
Retrieved from "https://www.wikidoc.org/index.php?title=Template:Fenofibrate&oldid=942821"